Study of Oral Anthocyanins on Insulin Resistance
Type 2 Diabetes
About this trial
This is an interventional treatment trial for Type 2 Diabetes focused on measuring anthocyanin, blaeberries, bilberries, blueberries, mirtoselect, type 2 diabetes, insulin resistance, Adipose tissue, inflammation
Eligibility Criteria
Inclusion Criteria:
- Obese male subjects (BMI > 30)
- Aged > 40 and < 70 years of age
- Type 2 diabetes; subjects controlling their diabetes by diet alone or with impaired glucose tolerance
- All the obese subjects will have a waist circumference over 40 inches
- All subjects must live the Aberdeenshire area of Scotland
Exclusion Criteria:
Medical exclusion criteria:
Chronic illness, including:
- thromboembolic or coagulation disease,
- unregulated thyroid disease,
- kidney disease,
- hepatic disease,
- severe gastrointestinal disorders,
- pulmonary disease (e.g. chronic bronchitis, COPD),
- Alcohol or any other substance abuse,
- Eating disorders,
- Psychiatric disorders (including severe depression, lithium treatment, schizophrenia, severe behavioural disorders),
- Skin conditions on the abdomen,
- Allergy to skin dressings,
Medication exclusion criteria:
- Oral steroids,
- Tricyclic antidepressants, neuroleptics,
- Anticoagulants,
- Digoxin and antiarrhythmics,
- Chronic use of antiinflammatories (e.g. high doses of aspirin, ibuprofen),
- Insulin, Sulphonylureas, Thiazolidinediones (glitazones), metformin
Sites / Locations
- University of Aberdeen Rowett Institute of Nutrition and Health
Arms of the Study
Arm 1
Arm 2
Active Comparator
Placebo Comparator
Blaeberry concentrated caspule
Placebo capsules containing lactose
30 obese male subjects (BMI > 30) with type 2 diabetes controlling their diabetes by diet alone or impaired glucose tolerance. Volunteers will be given a total daily dose of 1.4 grams of mirtoselect (a concentrated blaeberry extract) a day formulated in hard gelatin capsules (0.47 gram per capsule) administered thrice a day for 21 days. Mirtoselect provided by Indena S.p.A. (http://www.mirtoselect.info/)
30 obese male subjects (BMI > 30) with type 2 diabetes controlling their diabetes by diet alone or impaired glucose tolerance. Volunteers will be given a placebo consisting of lactose formulated in hard gelatin capsules administered thrice a day for 21 days.